The purpose of the study is to determine the nature of abnormalities in COPD patients and to determine whether hyperpolarized gas, xenon-129, MRI can detect changes in lung function following commonly used, FDA-approved treatment for COPD.
The study may involve spirometry, 6 minute walk test, electrocardiogram (ECG), chest CT, finger stick and a physical exam along with the MRI with inhaled xenon gas, depending on your qualifications.
The study involves up to 4 study visits, each lasting from 2-3 hours.
Study-related drugs and tests including spirometry, 6 minute walk test, physical exam, chest CT, finger stick and MRI with xenon provided at no cost to the subjects
Compensation up to $600 for study completion (based on the tests completed)